NASDAQ:INAB | Free Cash Flow | IN8BIO, INC.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2020-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$4.95M
2025-12-31-$2.14M
2025-03-31-$3.12M$0.00-$3.12M
2024-12-31-$4.03M
2024-03-31-$7.92M$50,000.00-$7.97M
2023-12-31-$4.85M
2023-03-31-$7.44M$371,000.00-$7.81M
2022-12-31-$7.95M
2022-03-31-$4.56M$8,000.00-$4.57M
2021-12-31-$2.18M
2021-03-31-$2.51M
2020-12-31-$1.73M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$12.71M
2024-12-31-$24.15M
2023-12-31-$23.34M
2022-12-31-$24.12M
2021-12-31-$13.51M
2020-12-31-$7.13M